IL6 and Hand-foot syndrome: Being an immunomodulatory that works by the inhibition of calcineurin phosphatase—which, in turn, downregulates the production of IL-1 and IL-6 [121]—we may conclude that TAC creates its protective effect by inhibition of the inflammatory pathway that occurs upon exposure of the HFs to cytotoxic agents.